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Abstract If we predict the host range of new or mutant
influenza virus in advance, we are able to measure against
pandemic human influenza immediately after the new virus
emerges somewhere. Influenza viral hemagglutinin(HA)–
sialoside receptor interaction is a target event for in silico
chemical prediction studies about the virus host range
determination. We theoretically studied avian and human
influenza A virus HA H3 subtype complexed with avian or
human type receptor Neu5Acα(2-3 or 2-6)Gal analogues
by ab initio fragment molecular orbital (FMO) method at
the second order Møller–Plesset (MP2)/6–31G level, which
can evaluate correctly not only electrostatic interactions
but also lipophilic interactions based on van der Waals
dispersion force. Avian H3 bound to avian α2-3 11.4
kcal/mol stronger than to human α2-6 in the model com-
plexes with taking account of intermolecular lipophilic
interaction. A substitution at the position 226 between Gln
(avian) and Leu(human) on influenza H3 HA1 has altered
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its virus host range between avian and human. In the ab
initio FMO studies, binding energy of avian Gln226Leu
H3–human α2-6 was quite similar to that in the human H3–
human α2-6 complex with amino acid sequence differences
at nine positions in the models. This similarity indicates
that avian Gln226Leu H3 virus can infect human with
the same level as human H3 virus. Opposite mutation
Leu226Gln in the human H3 gave the moderate binding
energies to avian α2-3 with similarity to avian H3–α2-3
complex that supported our previous virus-sialoside binding
assay. Ab initio FMO studies have revealed the relationship
between influenza H3 virus host range and H3–α(2-3 or
2-6) receptors binding. Our theoretical approach may pre-
dict the infectious level of new viruses and point out some
unknown dangerous mutation positions on HA in advance.
Keywords Influenza virus . Hemagglutinin .
Sialosaccharide . Virus host range . Ab initio FMO
Introduction
Avian H5N1 virus has a high potential for pandemic
influenza. The original H5N1 avian viruses can bind to avian
type receptors on human lower respiratory tract [1, 2],
however, this infection mechanism does not cause pandemic
human influenza. We should always take precaution against
when single or double point mutations occur in H5N1 viral
hemagglutinin and its higher binding affinity to human type
receptor [3–6].
If we predict the host range of new or mutant influenza
virus in advance, we are able to measure against pandemic
human influenza immediately after the new virus emerges
somewhere. Influenza virus host range is mainly deter-
mined by HA binding affinity to host cell surface receptors
sialo-glycolipids and -glycoproteins terminating in sialic
acid α2-3 or α2-6 galactose [7–10], therefore the HA–
sialoside interaction is a target event for in silico chemical
prediction studies about the virus host range determination.
Quantum chemical calculations will provide various chem-
ical foresights about HA–sialosaccharide interaction without
treatments of unknown dangerous influenza virus mutants.
We are attempting to construct HA–sialoside complex
models in order to explain the HA binding specificity using
H3 subtype system [11–12]. Our current interest is focused
on avian virus HA–Neu5Acα(2-3/6)Gal bindings and
comparison between avian HA mutant–human α2-6 inter-
action and the original human HA–human α2-6 interaction.
Avian influenza A virus H3 subtype has Gln226 as one
of the amino acids on sialoside binding site HA1 that binds
to avian type receptor N-acetylneuraminic acid (Neu5Ac)
α2-3 galactose (Gal) oligosaccharide stronger than to
human type receptor Neu5Acα(2-6)Gal [13]. We remark
that avian H3 weakly and certainly recognize human
receptor α2-6 [14] on TLC-virus binding assay using
synthetic sialylparaglobosides or corresponding B30 deriv-
atives [14–18] that is supported by X-ray crystallographic
structure of avian H3–human α2-6 complex [19]. Thus, it
is significant to analyze the relationship between avian
H3 binding affinity and the corresponding avian H3–
Neu5Acα(2-3 or 2-6)Gal complexes. Human H3 virus has
Leu226 instead of Gln that strongly recognizes human
receptor α2-6 sialosaccharide [13, 20–24]. In the human H3
subtype, point mutations on the sialoside binding site at
Tyr98Phe, His183Phe, and Leu194Ala decrease their
hemagglutination to human erythrocytes [25]. Human
Ser193Ile H3 agglutinates α2-6 sialoside expressed eryth-
rocytes stronger than the original human H3 [26]. In
particular, a substitution from Leu226 to Gln at the position
226 in human H3 HA1 changes its binding specificity from
human α2-6 to avian α2-3 [16, 27–29]. Weis et al. have
reported X-ray crystal structure of human Leu226Gln H3
complexed with avian type receptor α2-3 sialyllactose [20].
For the purpose of theoretical clarification about the H3–
sialoside binding properties, we plausibly investigate the
binding affinities of H3–Neu5Acα(2-3 or 2-6)Gal com-
plexes by ab initio molecular orbital studies. It is worth
while researching the energy profile on all steps in the HA–
sialoside interaction composed of several events: encounter
the sialoside binding site with sialoside receptor, leaving
needless water solvent in the interaction process, thermo-
dynamical relaxation on HA–sialoside complex, and mul-
tivalent effect on HA–sialoside interaction. However, we
just urgently request a simple and essential approach with a
reasonable cost. Ab initio fragment molecular orbital
(FMO) calculations [30–39] to evaluate the binding
energies between HA and Neu5Acα(2-3/6)Gal receptors
are one of the promising strategies.
Ab initio FMO method has been applied in large
biochemical systems for quantum chemical analysis to mo-
lecular interaction [40–45]. In this method, HA–sialoside
complex is divided into fragments, and MO calculations are
carried out on each fragment and fragment pairs. The total
energy on the HA–sialoside complex is obtained as a sum-
mation of the fragment energies and interfragment interac-
tion energies (IFIEs) [30–32, 34, 46, 47].
Our previous ab initio FMO studies estimated the
binding energies between influenza H3 and Neu5Acα(2-3/
6)Gal receptors at the FMO-Hartree-Fock(HF)/STO–3G
level, and analyzed IFIEs between Neu5Ac-Gal receptor
and amino acid residues on the sialoside binding site to
confirm qualitatively avian H3–avian α2-3 binding affinity
based on electrostatic interactions [11]. This approach
would be valid qualitatively, but the FMO-HF/STO–3G
method cannot evaluate significantly weak interactions
such as intermolecular lipophilic stabilization which play
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important roles in biochemical systems. Taking account of
electron correlation effects is necessary for more quantita-
tive treatment of these stabilizations based on van der
Waals dispersion force. Recently, the FMO method has been
extended to correlated calculations, which can be performed
at the MP2 method [36, 48]. Including electron correlation
effect, we applied the FMO-MP2 method to HA–sialoside
model complexes and analyzed the hydrophilic and
lipophilic interactions between Neu5Ac-Gal and amino
acid residues on the sialoside binding site HA1 using IFIEs.
Methods
Energy minimized structures of avian H3 complexed with
Neu5Acα(2-3 or 2-6)Gal disaccharide analogues were
prepared from the corresponding X-ray crystallographic
structures [19] by molecular mechanics (MM) energy
calculation with the CFF force field [49] using Discovery
Studio 1.5.1 program as shown in our previous works[11,
12]. We mutated in silico avian H3 Gln226 to Leu in the
avian H3–human α2-6 disaccharide complex, changed α2-
6 bond dihedral angle to human Leu226 H3 type
orientation referring the crystal structure of Neu5Acα(2-6)
Galβ(1-4)GlcNAcβ(1-3)Galβ(1-4)Glc: LSTc complexed
with human H3 [50], and optimized its geometry by MM
calculation to make the energy minimum avian Gln226Leu
H3–human α2-6 complex. Optimum human H3–human
α2-6 complex was given in silico by modification of
crystallographic structure of human H3–Neu5Acα(2-3)
Galβ(1-4)Glc complex [51]. We replaced the α2-3 trisac-
charide receptor with Neu5Acα(2-6)Gal disaccharide based
on the common Neu5Ac residue and changed its α2-6
bond dihedral angle referring LSTc conformation complexed
with human H3 [50] that was similar manner to the previous
study [12]. Human Leu226Gln H3–avian α2-3 complex was
prepared by in silico point mutation from Leu226 to Gln in
the human H3–avian α2-3 complex [51], changed α2-3 bond
dihedral angle to avian Gln226 H3 type orientation [19]
referring the crystal structure of human Leu226Gln–avian
α2-3 complex [20] followed by geometry optimization. MM
calculations were carried out in vacuo with structural
determined water molecules in the crystal structures.
We cut out the H3–sialoside models (HA: N96–P99,
G129–Y161, G181–V196, and N216–I232, 70 amino acid
residues) from the optimum structures for ab initio FMO
calculations (Fig. 1A). This approach covers the amino acid
residues on the sialoside binding site especially position
226, besides whose range is outside of substitutions far
away from the binding site. Peptide terminals in the models
were treated as NH3 and COO similar manner to the
previous study [11]. Amino acid sequences of avian and
human H3 differ at ten positions with same secondary
structure as shown in Fig. 1B. The differences at positions
137, 145, 226, and 228 are located on the direct interaction
site to Neu5Ac-Gal disaccharides. Since there are few
electron density of water molecules around the sialoside
binding site–Neu5Acα(2-3/6)Gal analogue complex in the
H3 crystal structures, we computed the model complexes
by the FMO method without water molecules.
Single point energies of the model complexes were
computed at the FMO-HF level with STO–3G [11], 6–31G,
and 6–31G(d) basis sets, and the correlated FMO-MP2/6–
31G level of theory. The later method evaluates interfrag-
ment van der Waals type stabilization in the protein–ligand
complex. Stabilizations of CH–π interaction between tryp-
tophan and carbohydrate in the β-galactosidase-substrates
or products complex were calculated at the MP2/6–31+G(d)
level as 2.4–5.2 kcal/mol [52]. Stabilizing interaction energy
of the fucose-benzene complex was estimated 3.0 kcal/mol
at the MP2/6–31G(d,p) level of theory [53].
The 70 amino acids on the H3-sialoside complexes were
divided into one amino acid residue as a single fragment
using automatic fragmentation program in the ABINIT-MP
package, and Neu5Ac-Gal receptors were also treated as a
single fragment. The receptors and sialoside binding sites
were charged to −1 and +1. We calculated single point
energies of the complexes (Ecomplex), Neu5Ac-Gal (Ereceptor),
Fig. 1 Interaction site of avian influenza A virus HA H3 subtype
complexed with avian type receptor Neu5Acα(2-3)Gal analogue for
ab initio FMO studies. A Ribbon model; avian H3 sialoside binding
site; N96–P99, G129–Y161, G181–V196, and N216–I232. CPK
model; Neu5Acα(2-3)Gal disaccharide, B sequence alignments of
avian/human H3 in the model complexes. yellow; non-matching
residues, green; weak matching residues, light blue; strong matching
residues, red; helix, blue; sheet
Glycoconj J (2008) 25:805–815 807
and the binding sites (EH3) to estimate binding energies (ΔE)
between the receptor and H3 by the following expression;
ΔE=(Ereceptor+EH3)−Ecomplex. Ab initio FMO calculations
were performed by using ABINIT-MP program [30–39].
Results and discussion
Figures 2, 3, 4, and 5 show the direct interactions between
Neu5Ac-Gal and sialoside binding site on H3 HA1.
Binding energies ΔE and the selected IFIEs of
Neu5Acα(2-3 or 2-6)Gal with amino acid residues at the
FMO-HF/STO–3G and FMO-MP2/6–31G levels are sum-
marized in Tables 1, 2, 3, 4, and 5.
ΔEs are estimated with electron correlation at the FMO-
MP2/6–31G level (Table 1). In the avian H3 complexes,
MP2/6–31G ΔEs are 43.5 and 40.3 kcal/mol larger than the
corresponding HF/STO–3G energies to give ΔEα2-3–ΔEα2-6
11.4 kcal/mol (entries 1, 3). Extension from minimal basis
sets to valence double zeta basis sets at the HF level affords
Fig. 3 Intermolecular interactions of Neu5Acα(2-3/6)Gal with amino
acid residues on the sialoside binding site in avian H3. A–C; avian
H3–avian α2-3 complex. D–F; avian H3–human α2-6 complex. The
red and black dotted lines represent hydrogen bonds and long range
interactions whose distances are given in angstrom
Fig. 2 Stereo depiction of the
avian H3–α(2-3/6) complexes.
left: avian H3-avian α2-3
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the differences ΔEα2-3–ΔEα2-6 13.1 kcal/mol in the avian
H3–α(2-3/6) complexes.
As shown in Tables 2 and 3, various intermolecular
lipophilic interactions benefit forming H3–Neu5Acα(2-3/6)
Gal complexes at the FMO-MP2/6–31G level. Neu5-
NHCOCH3 makes CH–π interaction network with Trp153
and Ile230 to afford MP2/6–31G IFIEs 8.5 and 8.6 kcal/
mol in avian H3–α(2-3/6) complexes, 4.0 kcal/mol in
human H3–human α2-6 complex (Figs. 3B, E, and 5B,
Tables 2 and 3; entry 5), while the corresponding HF/STO–
3G energies do not evaluate the CH–π interaction stabili-
zation. Gly134 and Thr155 directly interact with Neu 5-
NHCOCH3, but do not contribute to the HA–α(2-3/6)
binding (Tables 2 and 3; entries 6, 12). Hydrophobic
association between Leu194 and Neu7-CH, 9-CH2 has
bonding IFIEs 2.4–3.7 kcal/mol at the MP2/6–31G level
(Figs. 3C, F, and 5C, Tables 2 and 3; entry 13).
Intermolecular hydrophilic interactions also advantage the
forming HA–sialoside complex. In the avian H3 com-
plexes, MP2/6–31G IFIEs are 5.4–9.1 kcal/mol larger than
the corresponding HF/STO–3G energies (Table 2; entries 1,
2, 4, 8, 10). Especially, Gln226 on avian H3 interacts with
avian α2-3 whose MP2/6–31G IFIE is estimated 15.1 kcal/
mol larger than its HF/STO–3G energy (Fig. 3A, Table 2;
entry 3). In contrast, IFIE between Ser137 and Neu 1-
CO1O1’ has 33.9 kcal/mol at the MP2/6–31G which is
2.6 kcal/mol smaller than the HF/STO–3G energy (Fig. 3B,
Table 2; entry 9). Gly135 clearly forms an intermolecular
hydrogen bond with Neu 5-NHCOCH3, but whose IFIE are
quite smaller than the others (Tables 2 and 3; entry 7).
In the following section, we discuss molecular interac-
tion between Neu5Acα(2-3/6)Gal and amino acid residues
on the sialoside binding site in each complex with ΔEs and
IFIEs at the FMO-MP2/6–31G level.
Avian H3–Neu5Acα(2-3 or 2-6)Gal complexes
Avian H3 binds to avian receptor Neu5Acα(2-3)Gal
11.4 kcal/mol stronger than to human receptor Neu5Acα
(2-6)Gal with taking account of intermolecular lipophilic
stabilization at the FMO-MP2/6–31G level (Table 1; entries 1,
3). In the avian H3–avian α2-3 complex, side chain NH2CO
on Gln226 forms intermolecular hydrogen bond network
with 8-OH, 1-COO on Neu5Ac, Gal 4-OH, and weakly with
glycoside oxygen O3 to give IFIE 23.9 kcal/mol, which is
6.5 kcal/mol larger than the corresponding IFIE in avian H3–
human α2-6 complex (Fig. 3A, D, Table 2; entry 3). Besides,
hydrogen bond formations of Neu 1-COO with Ser136,
Ser137 and Asn145 strongly stabilize the avian H3–avian
α2-3 complex by IFIEs 27.1, 33.9, and 13.2 kcal/mol
(Fig. 3B, E, Table 2; entries 8–10). The later interaction
consists of intermolecular hydrogen bonds between Asn145
side chain CONH2 and O1’O1C1 on Neu5Acα(2-3)Gal with
2.78 Å. Gly228 on influenza A virus H3 subtype correlates
with the shift of virus host range between avian and human.
In our study, Gly228 interacts with Neu5Acα(2-3/6)Gal
disaccharides by IFIEs 4.7 and 4.3 kcal/mol (Fig. 3C, F,
Table 2; entry 11).
Fig. 5 Intermolecular interactions of human Neu5Acα(2-6)Gal with amino acid residues on the sialoside binding site in human H3
Fig. 4 Stereo depiction of the human H3–human α2-6 complex
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Table 3 Interfragment interaction energies of human Neu5Acα(2-6)Gal with amino acid residues on the sialoside binding site in human H3
Entry Human H3 amino acid Interaction sites on Neu5Acα(2-6)Gal HF/STO–3G MP2/6–31G
1 His183 Neu 8,9-OH 3.5 8.9
2 Tyr98 Neu 8-OH 6.4 16.2
3 Leu226 Gal 6-CH2 −1.3 6.1
4 Ala138 Neu 1-CO1O1′ 8.6 15.7
5 Trp153 Neu 5-NHCOCH3 −0.2 4.0
6 Gly134 Neu 5-NHCOCH3 −1.2 −0.9
7 Gly135 Neu 5-NHCOCH3 1.0 1.1
8 Ser136 Neu 1-CO1O1′ 24.2 29.3
9 Asn137 Neu 1-CO1O1′ 38.5 45.5
10 Ser145 Neu 1-CO1O1′ 0.0 2.6
11 Ser228 Neu 9-OH 6.8 14.8
12 Thr155 Neu 5-NHCOCH3 −1.6 −0.3
13 Leu194 Neu 7-CH, 9-CH2 −2.0 2.4
14 Sum 145.3
Table 1 Binding energies ΔE
between H3s and Neu5Acα(2-
3/6)Gal estimated by ab initio
FMO calculations
aΔEs were given in kilocalo-
ries per mole
b These data were previously
reported in [11]
Entry ΔEa H3 HF/STO–3G MP2/6–31G
1 ΔEα2–3 Avian 136.9
b 180.4
2 Human Leu226Gln 137.6 179.7
3 ΔEα2–6 Avian 128.7
b 169.0
4 Avian Gln226Leu 118.2b 157.6
5 Human 117.9 154.3
Table 2 Interfragment interaction energies of Neu5Acα(2-3/6)Gal with amino acid residues on the sialoside binding site in avian H3
Entry Avian H3
amino acid
Interaction sites on Neu5Acα(2-3/6)Gal α2-3 α2-6
α2-3 α2-6 HF/STO–3Ga MP2/6–31G HF/STO–3Ga MP2/6–31G
1 His183 Neu 8,9-OH 5.2 12.4 7.5 14.5
2 Tyr98 Neu 8-OH 6.7 14.6 5.1 14.2
3 Gln226 Neu 8-OH, 1-CO1O1′,
Gal 4-OH
Neu 8-OH, 1-CO1O1′ 8.8 23.9 10.5 17.4
4 Ala138 Neu 1-CO1O1′ 10.1 15.8 11.1 16.5
5 Trp153 Neu 5-NHCOCH3 0.1 8.5 −0.4 8.6
6 Gly134 Neu 5-NHCOCH3 −1.4 −1.3 −1.9 −1.8
7 Gly135 Neu 5-NHCOCH3 1.9 2.6 2.7 3.9
8 Ser136 Neu 1-CO1O1′ 20.5 27.1 16.2 23.2
9 Ser137 Neu 1-CO1O1′ 36.5 33.9 27.7 28.7
10 Asn145 Neu 1-CO1O1′ 6.6 13.2 10.7 18.2
11 Gly228 – 1.7 4.7 1.8 4.3
12 Thr155 Neu 5-NHCOCH3 −1.8 0.1 −2.2 −0.3
13 Leu194 Neu 7-CH, 9-CH2 −1.2 3.7 −1.8 2.5
14 Sum 159.2 149.9
IFIEs were given in kilocalories per mole. IFIEs will be estimated lower by FMO-MP2/6–31G(d) energy calculations of the corresponding
QM/MM optimum geometry
a IFIEs at the FMO-HF/STO–3G level were reported in [11]
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Comparison between ΔEs and sums of 13 IFIEs, the
formers are about 20 kcal/mol larger than the 13 IFIEs sums
(Table 1; entries 1, 3, Table 2; entry 14). IFIEs sum
difference of 9.3 kcal/mol mainly causes the binding energy
difference (ΔEα2-3–ΔEα2-6) of 11.4 kcal/mol. In the X-ray
crystal structure of avian H3 complexed with α(2-3 or 2-6)-
pentasaccharide receptors, the sialoside binding site reliably
recognizes the non-reducing terminal Neu5Ac-Gal [19] that
approximately allows our theoretical approach.
Human H3–Human Neu5Acα(2-6)Gal complex
Binding energy ΔE in the human H3–human Neu5Acα(2-
6)Gal disaccharide was estimated 154.3 kcal/mol at the
FMO-MP2/6–31G level (Table 1; entry 5). Human H3
complex has an intramolecular hydrogen bond at Neu 8-
OH∙∙∙O1C1O1’ instead of intermolecular Gln226∙∙∙Neu5Ac
interaction observed in the avian H3 complex (Fig. 5A), thus
ΔE in the human H3 complex is smaller by 15 kcal/mol
than the corresponding ΔE in the avian Gln226 H3
complex (Table 1; entries 3, 5). Neu 1-COO interacts with
Ser136 by 29.3 kcal/mol, Asn137 by 45.5 kcal/mol, and
Ser145 by 2.6 kcal/mol (Table 3; entries 8–10) whose
summation is larger by 7.3 kcal/mol than that in the avian
H3–human α2-6 complex (Table 2; entries 8–10). Intermo-
lecular hydrogen bond network between His183, Tyr98
and Neu 9,8-OH stabilizes the human H3–human α2-6
complex with IFIEs of 8.9 and 16.2 kcal/mol (Fig. 5C,
Table 3; entries 1, 2), therefore human Tyr98Phe or
His183Phe H3 viruses lose this stabilization by hydrogen
bonds decomposition to decrease severely their binding
affinities [25]. Tyr98 forms a hydrogen bond with His183
by IFIE of 10.5 kcal/mol, and CH–π interaction with
Leu226 by 1.2 kcal/mol.
Inter- and intra-molecular lipophilic association is
significant for the human H3–human α2-6 binding.
Leu226 interacts with Gal 6-CH2 on human α2-6 by
lipophilic IFIE of 6.1 kcal/mol (Fig. 5A, Table 3; entry 3)
Table 4 Interfragment
interaction energies of human
Neu5Acα(2-6)Gal with
amino acid residues on the
sialoside binding site in
avian Gln226Leu H3
Entry Avian Q226L H3 amino acid Interaction sites on Meu5Acα(2-6)Gal MP2/6–31G
1 His183 Neu 8,9-OH 14.3
2 Tyr98 Neu 8-OH 14.5
3 Leu226 Gal 6-CH2 4.8
4 Ala138 Neu 1-CO1O1′ 16.5
5 Trp153 Neu 5-NHCOCH3 8.6
6 Gly134 Neu 5-NHCOCH3 −1.6
7 Gly135 Neu 5-NHCOCH3 3.6
8 Ser136 Neu 1-CO1O1′ 25.0
9 Ser137 Neu 1-CO1O1′ 26.2
10 Asn145 Neu 1-CO1O1′ 18.1
11 Gly228 – 4.4
12 Thr155 Neu 5-NHCOCH3 −0.2
13 Leu194 Neu 7-CH, 9-CH2 2.7
14 Sum 136.9
Table 5 Interfragment
interaction energies of avian
Neu5Acα(2-3)Gal with
amino acid residues on the
sialoside binding site in
human Leu226Gln H3
Entry Human L226Q H3 amino acid Interaction sites on Neu 5Acα(2-3)Gal MP2/6–31G
1 His183 Neu 8,9-OH 8.6
2 Tyr98 Neu 8-OH 15.6
3 Gln226 Neu 8-OH, 1-CO1O1′, Gal 4-OH 31.3
4 Ala138 Neu 1-CO1O1′ 15.2
5 Trp153 Neu 5-NHCOCH3 7.9
6 Gly134 Neu 5-NHCOCH3 −1.3
7 Gly135 Neu 5-NHCOCH3 2.6
8 Ser136 Neu 1-CO1O1′ 27.4
9 Asn137 Neu 1-CO1O1′ 49.1
10 Ser145 Neu 1-CO1O1′ 3.1
11 Ser228 Neu 9-OH 14.3
12 Thr155 Neu 5-NHCOCH3 −0.4
13 Leu194 Neu 7-CH, 9-CH2 1.6
14 Sum 175.0
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that is supported by a lipophilic network beyond Leu226
consisted Tyr98, Pro99, Ala138, (CH2)3 on Arg220 and
Arg229, Ile230, and Trp153. Hydrophobic site on Neu 7-
CH 9-CH2 associates with lipophilic Leu194 by IFIE of
2.4 kcal/mol (Fig. 5C, Table 3; entry 13) supported by
hydrophobic groups around Leu194 such as Thr155,
Tyr195, (CH2)2 on Glu190, and CH2 on Ser193. Since
human Leu194Ala H3 virus does not agglutinate human
erythrocyte [25], the lipophilic association around Leu194
is significant for the human H3–human α2-6 binding
affinity. A substitution at Ser193 to Ile in human H3 HA1
increases the hydrophobic capacity around Leu194 to give
higher binding affinity to human α2-6 [26]. The two
lipophilic networks around Leu226∙∙∙Gal 6-CH2 and
Leu194∙∙∙Neu 7-CH 9-CH2 are connected by a hydrogen
bond formation of indole NH Trp153 with OH Tyr195
(Fig. 5C). However, both substitutions Trp153Phe or
Tyr195Phe partially decrease its binding affinity [8, 25].
Avian Gln226Leu H3–Human Neu5Acα(2-6)Gal
and human Leu226Gln H3–Avian Neu5Acα(2-3)Gal
complexes
Figures 6 and 7 show the interaction of Neu5Ac-Gal
with avian Gln226Leu/human Leu226Gln H3s. Avian
Gln226Leu H3 moderately binds to human α2-6 with ΔE
157.6 kcal/mol at the FMO-MP2/6–31G level (Table 1;
entry 4). This binding energy is quite similar to ΔEα2-6
154.3 kcal/mol in the human H3 complex with amino acid
difference at nine positions (Fig. 1B), therefore avian
Gln226Leu H3 virus can infect human with the same level as
human H3 virus. In the avian Gln226Leu H3–human α2-6
complex, Leu226 associates with lipophilic Gal 6-CH2 whose
IFIE is smaller by 1.3 kcal/mol than that of Leu226∙∙∙Gal
6-CH2 interaction in the human H3 complex (Tables 3 and 4;
entry 3). Besides Neu 8-OH makes an intramolecular
hydrogen bond with O1C1O1’-Neu similar manner to that
in the human Leu226 H3 complex (Figs. 5A and 6).
Fig. 8 Binding energy profile at the FMO-MP2/6–31G level on the
relationship between influenza H3 virus host range and H3–α(2-3 or
2-6) receptors binding. ΔEs are shown in Table 1
Fig. 7 Intermolecular interactions of avian Neu5Acα(2-3)Gal with
amino acid residues on the sialoside binding site in human Leu226Gln H3
Fig. 6 Intermolecular interactions of human Neu5Acα(2-6)Gal
with amino acid residues on the sialoside binding site in avian
Gln226Leu H3
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Human Leu226Gln H3 interacts with avian α2-3 by
ΔEα2-3 of 179.7 kcal/mol that is almost the same value as
ΔEα2-3 of 180.4 kcal/mol in the avian H3 complex at the
FMO-MP2/6–31G level (Table 1; entries 1, 2). In the
human Leu226Gln H3–avian α2-3 complex, Gln226 makes
intermolecular hydrogen bond network with 8-OH, 1-
CO1O1’ on Neu5Ac and Gal 4-OH to give IFIE
31.1 kcal/mol (Fig. 7, Table 5; entry 3). We previously
reported that A/Udorn Leu226Gln (human Leu226Gln
H3N2) bound to avian α2-3 receptor [14]. Our ab initio
FMO studies have confirmed that human Leu226Gln H3
moderately interacts with avian α2-3 analogue at the
correlated FMO-MP2/6–31G level.
Conclusion
We theoretically studied influenza A virus hemagglutinin
H3 subtype complexed with avian/human type receptor
Neu5Acα(2-3 or 2-6)Gal analogues by ab initio FMO
method at the correlated MP2/6–31G level. Avian H3
bound to avian α2-3 11.4 kcal/mol stronger than to human
α2-6 in the model complexes with taking account of
intermolecular lipophilic interaction. Single point substitu-
tion at the position 226 on H3 subtype sialoside binding site
HA1 changes its binding affinity between avian α2-3 and
human α2-6. Our ab initio FMO studies showed that the
binding energy of avian Gln226Leu H3 with human α2-6
was similar value to that in the human H3–human α2-6
complex at the FMO-MP2/6–31G level with amino acid
differences at nine positions in our models. Thus avian
Gln226Leu H3 virus can infect human with the same
level as human H3 virus. Opposite mutation Leu226Gln
in the human H3 gave the moderate binding energy to
avian α2-3 that supported our previous virus-sialoside
binding assay.
As shown in a schematic summary (Fig. 8), ab initio
FMO studies revealed the relationship between influenza
H3 virus host range and H3–α(2-3 or 2-6) receptors
binding. Our theoretical approach will predict the infectious
level of new viruses and point out some unknown
dangerous mutation positions on HA in advance against
human pandemic influenza.
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